Pentaerythrityl tetranitrate improves the outcome of children born to mothers with compromised uterine perfusion—12-months follow-up and safety data of the double-blind randomized PETN trial

This is a follow-up study to the pentaerythrityl tetranitrate randomized controlled multicenter trial that reports neonatal outcome data of newborns admitted to neonatal intensive care units and outcome data of the offspring at 12 months of age.